ArticleInternational journal of nanomedicine2026
Magnesium Oxide Nanoparticles Loaded with 6-Gingerol: A Bioinspired Approach to Anticancer, Anti-Inflammatory, and Antioxidant Therapy.
Article in International journal of nanomedicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: The aim of this work is to synthesize magnesium oxide nanoparticles (Gi-MgO NPs) by extracting 6-gingerol (Gi) from Methods: The physical and chemical characteristics were examined by FT-IR, HPTLC, XRD, XPS, HR-SEM, HR-TEM, EDX, and zeta potential. Proton ( Results: The Gi-loaded nanoparticles were shown to be more effective than 6-gingerol, as evidenced by their increased toxicity against the THP-1 cell line (IC Conclusion: The present investigation revealed Gi-MgO NPs significant anticancer effect and ability to cause apoptosis in malignant cells by modifying the expression of apoptosis-related genes; however, additional ex vivo and molecular mechanism studies are required.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.